The subject of the order is the delivery of medicinal products Packages 1-13, detailed in Annex 1 to the ToR

Lipegfilgrastimum, described in detail in Annex 1 to the ToR

Vemurafenib, described in detail in Annex 1 to the ToR

Zoledronic acid, described in detail in Annex 1 to the ToR

Levosimendan, described in detail in Annex 1 to the ToR

Octreotidum, described in detail in Annex 1 to the ToR

Melphalan, described in detail in Annex 1 to the ToR

Methotrexate, described in detail in Annex 1 to the ToR

Mitotanum, described in detail in Annex 1 to the ToR

Panitumumab, described in detail in Annex 1 to the ToR

Pazopanib, described in detail in Annex 1 to the ToR

Pegaspargase, described in detail in Annex 1 to the ToR

Sunitinib, described in detail in Annex 1 to the ToR

Topotecanum, described in detail in Annex 1 to the ToR